CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842,556 | -67.4% | 28,600 | -63.9% | 0.00% | -77.8% |
| Q2 2023 | $2,587,516 | -74.4% | 79,323 | -64.0% | 0.01% | -95.1% |
| Q4 2022 | $10,103,493 | +79.5% | 220,504 | +89.9% | 0.18% | +70.4% |
| Q3 2022 | $5,628,000 | +68.8% | 116,144 | +36.9% | 0.11% | +17.4% |
| Q2 2022 | $3,334,000 | +15.7% | 84,860 | +8.4% | 0.09% | +19.5% |
| Q1 2022 | $2,881,000 | +602.7% | 78,280 | +125.5% | 0.08% | -15.4% |
| Q1 2020 | $410,000 | +16.8% | 34,715 | +4.7% | 0.09% | +295.7% |
| Q4 2019 | $351,000 | +61.0% | 33,150 | +70.9% | 0.02% | -4.2% |
| Q2 2019 | $218,000 | – | 19,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |